Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 104

    1.

    Prostaglandin E1 increases in vivo and in vitro calcitriol biosynthesis in rabbits.

    Velásquez-Forero F, García P, Triffitt JT, Llach F.

    Prostaglandins Leukot Essent Fatty Acids. 2006 Aug;75(2):107-15. Epub 2006 Jul 28.PMID: 16876395 [PubMed - indexed for MEDLINE]Related articles

    2.

    Overview of renal bone disease: causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach.

    Llach F, Fernández E.

    Kidney Int Suppl. 2003 Nov;(87):S113-9. Review. No abstract available. PMID: 14531783 [PubMed - indexed for MEDLINE]Related articles

    3.

    The evolving clinical features of calciphylaxis.

    Llach F.

    Kidney Int Suppl. 2003 Jun;(85):S122-4. Review. No abstract available. PMID: 12753282 [PubMed - indexed for MEDLINE]Related articles

    4.

    Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.

    Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D.

    Kidney Int. 2003 Apr;63(4):1483-90.PMID: 12631365 [PubMed - indexed for MEDLINE]Related articles

    5.

    Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized study.

    Martin KJ, González E, Lindberg JS, Taccetta C, Amdahl M, Malhotra K, Llach F.

    Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S57-63.PMID: 11689389 [PubMed - indexed for MEDLINE]Related articles

    6.

    Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.

    Llach F, Yudd M.

    Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S45-50.PMID: 11689387 [PubMed - indexed for MEDLINE]Related articles

    7.

    Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.

    Llach F, Velasquez Forero F.

    Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S20-33. Review.PMID: 11689384 [PubMed - indexed for MEDLINE]Related articles

    8.

    The evolving pattern of calciphylaxis: therapeutic considerations.

    Llach F.

    Nephrol Dial Transplant. 2001 Mar;16(3):448-51. Review. No abstract available. PMID: 11239014 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Current medical management of secondary hyperparathyroidism.

    Yudd M, Llach F.

    Am J Med Sci. 2000 Aug;320(2):100-6. Review.PMID: 10981484 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hyperphosphatemia in end-stage renal disease patients: pathophysiological consequences.

    Llach F.

    Kidney Int Suppl. 1999 Dec;73:S31-7. Review.PMID: 10633461 [PubMed - indexed for MEDLINE]Related articles

    11.

    Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.

    Llach F, Keshav G, Goldblat MV, Lindberg JS, Sadler R, Delmez J, Arruda J, Lau A, Slatopolsky E.

    Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48-54.PMID: 9808143 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure.

    Llach F, Yudd M.

    Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S3-12. Review. No abstract available. PMID: 9808139 [PubMed - indexed for MEDLINE]Related articles

    13.

    Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?

    Llach F.

    Am J Kidney Dis. 1998 Sep;32(3):514-8. No abstract available. PMID: 9740172 [PubMed - indexed for MEDLINE]Related articles

    14.

    The importance of hyperphosphataemia in the severity of hyperparathyroidism and its treatment in patients with chronic renal failure.

    Llach F, Yudd M.

    Nephrol Dial Transplant. 1998;13 Suppl 3:57-61. Review. No abstract available. PMID: 9568822 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure?

    Martínez I, Saracho R, Moina I, Montenegro J, Llach F.

    Nephrol Dial Transplant. 1998;13 Suppl 3:9-11.PMID: 9568813 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.

    Martinez I, Saracho R, Montenegro J, Llach F.

    Am J Kidney Dis. 1997 Apr;29(4):496-502.PMID: 9100037 [PubMed - indexed for MEDLINE]Related articles

    17.

    Guidelines for dosing of intravenous calcitriol in dialysis patients with hyperparathyroidism.

    Fernandez E, Llach F.

    Nephrol Dial Transplant. 1996;11 Suppl 3:96-101. Review.PMID: 8840322 [PubMed - indexed for MEDLINE]Related articles

    18.

    A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism.

    Martinez I, Saracho R, Montenegro J, Llach F.

    Nephrol Dial Transplant. 1996;11 Suppl 3:22-8.PMID: 8840307 [PubMed - indexed for MEDLINE]Related articles

    19.

    The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism.

    Llach F, Hervas J, Cerezo S.

    Am J Kidney Dis. 1995 Nov;26(5):845-51.PMID: 7485143 [PubMed - indexed for MEDLINE]Related articles

    20.

    Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited.

    Llach F.

    Am J Kidney Dis. 1995 May;25(5):663-79. Review.PMID: 7747720 [PubMed - indexed for MEDLINE]Related articles

    21.

    Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat.

    Bover J, Rodriguez M, Trinidad P, Jara A, Martinez ME, Machado L, Llach F, Felsenfeld AJ.

    Kidney Int. 1994 Apr;45(4):953-61.PMID: 8007598 [PubMed - indexed for MEDLINE]Related articles

    22.

    Methods of controlling hyperphosphatemia in patients with chronic renal failure.

    Llach F, Nikakhtar B.

    Curr Opin Nephrol Hypertens. 1993 May;2(3):365-71. Review.PMID: 7922196 [PubMed - indexed for MEDLINE]Related articles

    23.

    Aluminum kinetics using bicarbonate dialysate with the sorbent system.

    Llach F, Gardner PW, George CR, Cairoli O.

    Kidney Int. 1993 Apr;43(4):899-902.PMID: 8479127 [PubMed - indexed for MEDLINE]Related articles

    24.

    Parathyroid gland function in chronic renal failure.

    Felsenfeld AJ, Llach F.

    Kidney Int. 1993 Apr;43(4):771-89.PMID: 8479113 [PubMed - indexed for MEDLINE]Related articles

    25.

    Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.

    Rodriguez M, Felsenfeld AJ, Llach F.

    Kidney Int. 1991 Dec;40(6):1063-8.PMID: 1762307 [PubMed - indexed for MEDLINE]Related articles

    26.

    Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.

    Rodriguez M, Martin-Malo A, Martinez ME, Torres A, Felsenfeld AJ, Llach F.

    Kidney Int. 1991 Dec;40(6):1055-62.PMID: 1762306 [PubMed - indexed for MEDLINE]Related articles

    27.

    The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.

    Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F.

    J Am Soc Nephrol. 1991 Nov;2(5):1014-20.PMID: 1760537 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Sigmoidal relationship between calcitonin and calcium: studies in normal, parathyroidectomized, and azotemic rats.

    Torres A, Rodriguez M, Felsenfeld A, Martin-Malo A, Llach F.

    Kidney Int. 1991 Oct;40(4):700-4.PMID: 1745020 [PubMed - indexed for MEDLINE]Related articles

    29.

    Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat.

    Rodriguez M, Felsenfeld AJ, Torres A, Pederson L, Llach F.

    Kidney Int. 1991 Aug;40(2):219-25.PMID: 1942770 [PubMed - indexed for MEDLINE]Related articles

    30.

    Renal bone disease.

    Llach F.

    Transplant Proc. 1991 Apr;23(2):1818-22. No abstract available. PMID: 2053165 [PubMed - indexed for MEDLINE]Related articles

    31.

    A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy.

    Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F.

    Nephrol Dial Transplant. 1991;6(4):244-51.PMID: 1881578 [PubMed - indexed for MEDLINE]Related articles

    32.

    Current advances in the therapy of secondary hyperparathyroidism and osteitis fibrosa.

    Llach F, Nikakhtar B.

    Miner Electrolyte Metab. 1991;17(4):250-5. Review.PMID: 1813787 [PubMed - indexed for MEDLINE]Related articles

    33.

    Osteocalcin levels in uremic patients: influence of calcitriol treatment through two different routes and type of dialysis.

    Martinez ME, Selgas R, Miguel JL, Balaguer G, Sanchez-Cabezudo MJ, Llach F.

    Nephron. 1991;59(3):429-33.PMID: 1758533 [PubMed - indexed for MEDLINE]Related articles

    34.

    Parathyroidectomy in chronic renal failure: indications, surgical approach and the use of calcitriol.

    Llach F.

    Kidney Int Suppl. 1990 Sep;29:S62-8. Review.PMID: 2214549 [PubMed - indexed for MEDLINE]Related articles

    35.

    Two-needle calculation of recirculation compared with the standard three-needle method.

    Pederson JA, Dunlay R, Williams C, Llach F.

    Clin Nephrol. 1990 Apr;33(4):203-6.PMID: 2350908 [PubMed - indexed for MEDLINE]Related articles

    36.

    Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat.

    Rodriguez M, Lorenzo V, Felsenfeld AJ, Llach F.

    J Bone Miner Res. 1990 Apr;5(4):379-86.PMID: 2343777 [PubMed - indexed for MEDLINE]Related articles

    37.

    Aluminum administration in the rat separately affects the osteoblast and bone mineralization.

    Rodriguez M, Felsenfeld AJ, Llach F.

    J Bone Miner Res. 1990 Jan;5(1):59-67.PMID: 2309580 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Osteomalacia and renal tubular acidosis associated with analgesic abuse. A clinical case]

    Valdivieso A, Flores F, Llach F, Felsenfeld AJ, Massardo L, Jacobelli S.

    Rev Med Chil. 1990 Jan;118(1):58-66. Review. Spanish. PMID: 1983808 [PubMed - indexed for MEDLINE]Related articles

    39.

    Insulin in the acute renal adaptation to dietary phosphate restriction in the rat.

    Allon M, Rodriguez M, Llach F.

    Kidney Int. 1990 Jan;37(1):14-20.PMID: 1967663 [PubMed - indexed for MEDLINE]Related articles

    40.

    Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.

    Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F.

    Kidney Int. 1989 Dec;36(6):1093-8.PMID: 2601258 [PubMed - indexed for MEDLINE]Related articles

    41.

    Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy.

    Marie PJ, Lomri A, de Vernejoul MC, Morieux C, Graulet AM, Guéris J, Llach F.

    J Clin Endocrinol Metab. 1989 Dec;69(6):1166-73.PMID: 2555383 [PubMed - indexed for MEDLINE]Related articles

    42.

    The evolution of osteomalacia in the rat with acute aluminum toxicity.

    Rodriguez M, Felsenfeld AJ, Llach F.

    J Bone Miner Res. 1989 Oct;4(5):687-96.PMID: 2816514 [PubMed - indexed for MEDLINE]Related articles

    43.

    Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation.

    de Vernejoul MC, Marchais S, London G, Bielakoff J, Chappuis P, Morieux C, Llach F.

    Am J Kidney Dis. 1989 Aug;14(2):124-30.PMID: 2757018 [PubMed - indexed for MEDLINE]Related articles

    44.

    Aluminum in renal disease.

    Llach F.

    J Am Coll Nutr. 1989 Aug;8(4):292-5. Review. No abstract available. PMID: 2674255 [PubMed - indexed for MEDLINE]Related articles

    45.

    Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.

    Felsenfeld AJ, Rodriguez M, Coleman M, Ross D, Llach F.

    Kidney Int. 1989 Jun;35(6):1371-8.PMID: 2770115 [PubMed - indexed for MEDLINE]Related articles

    46.

    Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome.

    Dunlay RW, Camp MA, Allon M, Fanti P, Malluche HH, Llach F.

    Ann Intern Med. 1989 Jan 15;110(2):162-4. No abstract available. PMID: 2909207 [PubMed - indexed for MEDLINE]Related articles

    47.

    Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients.

    London GM, de Vernejoul MC, Fabiani F, Marchais S, Guerin A, Metivier F, Chappuis P, Llach F.

    Am J Kidney Dis. 1989 Jan;13(1):75-83.PMID: 2521422 [PubMed - indexed for MEDLINE]Related articles

    48.

    Toxic effects of aluminum in end-stage renal disease: discussion of a case.

    Coburn JW, Norris KC, Sherrard DJ, Bia M, Llach F, Alfrey AC, Slatopolsky E.

    Am J Kidney Dis. 1988 Sep;12(3):171-84. No abstract available. PMID: 3414675 [PubMed - indexed for MEDLINE]Related articles

    49.

    Hyperphosphatemia, hypocalcemia, and renal failure in a patient with acute leukemia.

    Allon M, Llach F.

    Am J Kidney Dis. 1988 May;11(5):442-5. No abstract available. PMID: 3163467 [PubMed - indexed for MEDLINE]Related articles

    50.

    Arginine-induced hypermagnesemia and hyperkalemia in nephrectomized rats.

    Whang R, Papper S, Llach F.

    Magnesium. 1988;7(1):23-6.PMID: 3379978 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...